NCT05137210

Brief Summary

HIV self-testing (HIVST) has been found to be a highly acceptable approach for men to learn of their HIV status and has resulted in increased testing uptake. However, rates of antiretroviral therapy (ART) initiation among those tested with HIVST are difficult to capture. This clinical trial will test varying approaches to ART initiation and retention among men who test positive using HIVST to learn about the most effective strategy to engage men in ART services.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
569

participants targeted

Target at P75+ for not_applicable hiv

Timeline
Completed

Started Sep 2021

Typical duration for not_applicable hiv

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

November 30, 2021

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2025

Completed
Last Updated

July 6, 2023

Status Verified

July 1, 2023

Enrollment Period

3.5 years

First QC Date

May 28, 2021

Last Update Submit

July 3, 2023

Conditions

Keywords

HIV self-testing (HIVST)HIVAntiretroviral therapy (ART)ART InitiationART RetentionMenHIVST

Outcome Measures

Primary Outcomes (1)

  • Proportion of men who are retained on ART early

    Proportion of men who initiate ART at 3-months and attended their 4-week ART refill appointment at 4-month after enrollment. Sourced from medical chart reviews.

    4-months.

Secondary Outcomes (2)

  • Proportion of men who initiate ART

    3-months

  • Any adverse events self-reported by female ART client or male partner

    4-months

Study Arms (3)

Male-specific counseling and facility navigation

EXPERIMENTAL
Other: Male Counseling and Facility Navigation

Home-Based ART Initiation

EXPERIMENTAL
Other: Home-Based ART Initiation and Facility Navigation

Stepped Intervention

EXPERIMENTAL
Other: Stepped Intervention

Interventions

At enrollment, study staff distribute pamphlet with male-specific messaging and contact information for nearest facility. Low-level cadre traces participants and provides one-on-one, in person male-specific counseling. Meeting at location of participants choice. Follow-up male-specific counseling is offered every 14 days thereafter until 90 days is reached OR 4-week follow-up ART refill visit is completed. Participants who choose to initiate ART are escorted to nearest health facility and provided facility navigation assistance.

Male-specific counseling and facility navigation

At enrollment, study staff distribute two pamphlets on: 1) male-specific messaging and 2) details about home-based ART initiation. Low-level cadre traces participants and provides one-on-one, in person male-specific counseling, and a detailed description of home-based ART initiation with a nurse. Meeting at the location of participants choice. Follow-up male-specific counseling and information about home-based initiation is offered every 14 days thereafter until 90 days OR 4-week ART follow-up refill visit is complete. Participants who choose to initiate ART at home or in the community will meet with a nurse at a place of the participants choosing. Those who choose to initiate at the facility will receive facility navigation and initiation. All clients will receive a "warm handover" for their 4-week ART follow-up visit.

Home-Based ART Initiation

Day 0-14 Arm 1 (Male-specific counseling and facility navigation arm) implemented. Day 14-30, if not yet initiated, a psychosocial counsellor will trace the participant to provide advanced counselling and motivational interviewing. Psychosocial counsellors will act as 'Male Mentors' and meet with men as frequently as needed. Day 30-89 if not yet initiated, nurse-led home-based ART initiation will be offered, following the same steps as listed in the "Home-Based ART Initiation" Arm.

Stepped Intervention

Eligibility Criteria

Age15 Years+
Sexall(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • ≥15 years of age
  • Tested HIV positive using Ministry of Health standard algorithm (Determine + Unigold)
  • Not currently engaged in ART services, defined as:
  • Tested HIV-positive ≥14 days and not on ART ≥14 days after testing HIV-positive;
  • ≥14 days late for the first four-week follow up appointment; or
  • Initiated ART but ≥60 days late for last ART appointment;
  • Has not taken ART in the past 7-days, as indicated by a point of care (POC) urine assay
  • Living inside the facility catchment area (defined as any area that HCWs from the study facility routinely visit for tracing purposes)

You may not qualify if:

  • \<15 years of age
  • Never tested HIV positive using Ministry of Health standard algorithm (Determine + Unigold)
  • Tested HIV-positive \<14 days ago
  • Currently engaged in ART services, defined as:
  • Initiated ART
  • \<14 days late for the first four-week follow up appointment
  • Initiated ART and \<60 days late for last ART appointment
  • Has taken ART in the past 7-days, as indicated by a point of care (POC) urine assay
  • Living outside the facility catchment area (defined as any area that HCWs from the study facility routinely visit for tracing purposes)
  • Female partner
  • ≥15 years of age
  • Male partner enrolled in the study
  • Male partner agrees that the female can be recruited for an in-depth interview
  • \<15 years of age
  • Male partner is not enrolled in the study
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Partners in Hope

Lilongwe, Malawi

Location

Related Publications (3)

  • Hubbard J, Mphande M, Robson I, Balakasi K, Phiri K, Chikuse E, Thorp M, Phiri S, Choko AT, Cornell M, Coates T, Dovel K. Core components of male-specific person-centred HIV care: a qualitative analysis from client and healthcare worker perspectives in Malawi. BMJ Public Health. 2024 Dec 22;2(2):e001100. doi: 10.1136/bmjph-2024-001100. eCollection 2024 Dec.

  • Holland KN, Hubbard J, Mphande M, Robson I, Phiri K, Onoya D, Chikuse E, Dovel K, Choko A. Implementation of Male-Specific Motivational Interviewing in Malawi: An Assessment of Intervention Fidelity and Barriers to Scale-Up. medRxiv [Preprint]. 2024 Sep 26:2024.09.24.24314326. doi: 10.1101/2024.09.24.24314326.

  • Dovel K, Balakasi K, Hubbard J, Phiri K, Nichols BE, Coates TJ, Kulich M, Chikuse E, Phiri S, Long LC, Hoffman RM, Choko AT. Identifying efficient linkage strategies for men (IDEaL): a study protocol for an individually randomised control trial. BMJ Open. 2023 Jul 12;13(7):e070896. doi: 10.1136/bmjopen-2022-070896.

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeMultiple Endocrine Neoplasia Type 1

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesMultiple Endocrine NeoplasiaEndocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsNeoplasms, Multiple PrimaryNeoplastic Syndromes, HereditaryGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 28, 2021

First Posted

November 30, 2021

Study Start

September 1, 2021

Primary Completion

March 15, 2025

Study Completion

June 15, 2025

Last Updated

July 6, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in an article after deidentification (text, tables, figures and appendices).

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Beginning three months and ending five years following article publication.
Access Criteria
Researchers who provide a methodologically sound proposal. Proposals should be sent to Dr. Dovel (kdovel@mednet.ucla.edu). To gain access, data requestors will need to sign a data access agreement. Data are available for five years.

Locations